NSC |
Compound |
Enrichment |
Correlation |
NSC 744076 |
Null |
0.0295480456086945 |
0.23645463 |
NSC 749160 |
Null |
0.0295480456086945 |
0.35420148 |
NSC 751830 |
2-(4-hydroxypiperidin-1-yl)-4-(4-morpholinophenylamino)pyrido[4,3-d]pyrimidin-5(6H)-one |
0.0295480456086945 |
-0.12471366 |
NSC 132275 |
Ethanesulfonic acid, compd. with 2-(2-chloro-4-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)phenoxy)acetanilide (1:1) |
0.0295480456086947 |
0.5422039 |
NSC 132277 |
Ethanesulfonic acid, compd. with 1,6-dihydro-6,6-dimethyl-1-[4-(4-phenylbutyl)phenyl]-1,3,5-triazine-2,4-diamine (1:1) |
0.0295480456086947 |
0.54881915 |
NSC 133118 |
2H-1,2,3-Triazolo[4,5-d]pyrimidin-7-amine, 2-.beta.-D-ribofuranosyl- (9CI) |
0.0295480456086947 |
0.15796327 |
NSC 208885 |
Null |
0.0295480456086947 |
0.35932971 |
NSC 31780 |
3H-Indolium, 2-[3-(1,3-dihydro-1,3,3-trimethyl-2H-indol-2-ylidene)-1-propenyl]-1,3,3-trimethyl-, chloride (9CI) |
0.0295480456086947 |
0.58897706 |
NSC 319947 |
2,4-Pyrimidinediamine, 5-(3-azido-4-chlorophenyl)-6-ethyl- |
0.0295480456086947 |
0.35912606 |
NSC 330507 |
Tanespimycin |
0.0295480456086947 |
0.32827273 |